Porcine Blood and Surrogate Markers Do Not Prove Benefit of aDabi-Fab

Critical Care - United Kingdom
doi 10.1186/cc13927
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Commentary: Del Nido Cardioplegia – Can We and Do We Need to Prove the Benefit?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Anti-Leukotrienes Do Not Benefit Asthma

BMJ
2002English

Surrogate Markers of Antiangiogenic Therapies

2012English

Surrogate Markers for Cardiovascular Disease: Structural Markers

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Evaluation of Surrogate Markers for Human Immunodeficiency Virus Infection Among Blood Donors at the Blood Bank of "Hospital Universitário Regional Norte Do Paraná", Londrina, PR, Brazil

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
2003English

Lymphocyte Subsets as Surrogate Markers in Antiretroviral Therapy

Infection
MedicineInfectious DiseasesMicrobiology
1991English

Neurofilament Phosphoforms: Surrogate Markers for Axonal Injury, Degeneration and Loss

Journal of the Neurological Sciences
Neurology
2005English

Binding of Fab-Horseradish Peroxidase Conjugates by Charge and Not by Immunospecificity.

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1985English

Exosomes in HNSCC Plasma as Surrogate Markers of Tumour Progression and Immune Competence

Clinical and Experimental Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy